Skip to main content
Log in

TGA warns against off-label use of SGLT-1 inhibitors for T1DM

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. sodium glucose transporter-2 inhibitors

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TGA warns against off-label use of SGLT-1 inhibitors for T1DM. Reactions Weekly 1896, 5 (2022). https://doi.org/10.1007/s40278-022-10796-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-10796-3

Navigation